Liquid chromatography-mass spectrometry-based metabolomics study of the protective mechanism of Shenji Guben decoction on chronic obstructive pulmonary disease.
- 1 October 2025
- journal article
- Vol. 45 (5) , 1009-1018
Abstract
To investigate the mechanisms of the effect of Shenji Guben (SJGB) decoction on chronic obstructive pulmonary disease (COPD). A murine model of COPD was established through lipopolysaccharide (LPS) nasal drops and passive smoke exposure, followed by evaluation of SJGB decoction efficacy via lung function tests and histological analysis. Non-targeted liquid chromatography-mass spectrometry (LC-MS)-based metabolomics was used to explore the mechanisms of SJGB decoction in COPD. We found that the SJGB decoction effectively reduced inflammatory cell infiltration in the airways and lungs, and improved lung function in the COPD model mice. LC-MS-based metabolomics identified 86 biomarkers in COPD models. Compared to the model group, SJGB decoction significantly altered 34 metabolites. Prostaglandin E2 and DL-Citrulline were highlighted as two representative differential metabolites. MetaboAnalyst 5.0 highlighted glycerophospholipid and riboflavin metabolisms as key pathways affected by SJGB decoction. This study evaluated the protective effect of SJGB decoction against COPD and provided insights into its potential mechanisms in COPD treatment.Keywords
This publication has 26 references indexed in Scilit:
- Alveolar lipids in pulmonary disease. A reviewLipids in Health and Disease, 2020
- Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017The Lancet Respiratory Medicine, 2020
- Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice GuidelineAmerican Journal of Respiratory and Critical Care Medicine, 2020
- An Updated Overview of Metabolomic Profile Changes in Chronic Obstructive Pulmonary DiseaseMetabolites, 2019
- Metabolomics in chronic lung diseasesRespirology, 2019
- Frontiers of high-throughput metabolomicsCurrent Opinion in Chemical Biology, 2017
- Multiplatform Analytical Methodology for Metabolic Fingerprinting of Lung TissueAnalytical Chemistry, 2013
- Riboflavin Status in Acutely Ill Patients and Response to Dietary SupplementsJournal of Parenteral and Enteral Nutrition, 2009
- The Pathology of Chronic Obstructive Pulmonary DiseaseAnnual Review of Pathology: Mechanisms of Disease, 2009
- Projections of Global Mortality and Burden of Disease from 2002 to 2030PLOS Medicine, 2006